Insider · CIK 0001318470
Daniel M Schmitt
Files at ACTU (ACTUATE THERAPEUTICS, INC.). First filing -, latest -.
In brief
Daniel M Schmitt files SEC Form 4 as CEO, president and director at ACTU (ACTUATE THERAPEUTICS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Daniel M Schmitt has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | ACTU ACTUATE THERAPEUTICS, INC. | MOption exercise Common Stock | +272,056 | $0.00 | $0 | 422,237 | Aug 14, 2026 |
| Aug 14, 2026 | ACTU ACTUATE THERAPEUTICS, INC. | FTax withholding Common Stock | -120,521 | $1.01 | $122k | 301,716 | Aug 14, 2026 |
| Aug 14, 2026 | ACTU ACTUATE THERAPEUTICS, INC. | MOption exercise Restricted Stock Unitsderivative | -272,056 | $0.00 | $0 | 0 | Aug 14, 2026 |
| Apr 1, 2026 | ACTU ACTUATE THERAPEUTICS, INC. | AGrant or award Employee Stock Option (right to buy)derivative | +237,000 | $0.00 | $0 | 237,000 | Apr 1, 2026 |
| Feb 13, 2026 | ACTU ACTUATE THERAPEUTICS, INC. | MOption exercise Common Stock | +272,055 | $0.00 | $0 | 272,055 | Feb 13, 2026 |
| Feb 13, 2026 | ACTU ACTUATE THERAPEUTICS, INC. | FTax withholding Common Stock | -121,874 | $4.33 | $528k | 150,181 | Feb 13, 2026 |
| Feb 13, 2026 | ACTU ACTUATE THERAPEUTICS, INC. | MOption exercise Restricted Stock Unitsderivative | -272,055 | $0.00 | $0 | 272,056 | Feb 13, 2026 |
| Apr 1, 2025 | ACTU ACTUATE THERAPEUTICS, INC. | AGrant or award Employee Stock Option (right to buy)derivative | +66,503 | $0.00 | $0 | 66,503 | Apr 2, 2025 |
| Apr 1, 2025 | ACTU ACTUATE THERAPEUTICS, INC. | AGrant or award Employee Stock Option (right to buy)derivative | +204,285 | $0.00 | $0 | 204,285 | Apr 2, 2025 |
Questions about Daniel M Schmitt
Answered from the filings on this page, as of the latest one.
Is Daniel M Schmitt buying or selling?
Daniel M Schmitt has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Daniel M Schmitt's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Daniel M Schmitt has 0.
Where does Daniel M Schmitt file Form 4?
Daniel M Schmitt has filed Form 4 at ACTU (ACTUATE THERAPEUTICS, INC.) as President, CEO and Director. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.